Driving CAR-Ts for Treatment in Cancer and Immunology
A deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.
Scorpius to Unveil First Mammalian cGMP Campaign at Texas Plant
The San Antonio facility will be taking this biomanufacturing initiative by the end of Q3 2024.
Agilent Purchases Biovectra for $925 Million
The deal exponentially grows the CDMO’s biopharma capabilities.
Grünenthal Obtains Valinor Pharma
In a transaction valued at $250 million, the deal makes Grünenthal the new owner of Movantik, which treats OIC in adult patients with chronic non-cancer pain.
Pharma Pulse 7/23/24: The Data That Powers AI is Disappearing Fast, Stay Aware of Common High-Alert Medications & more
The latest news for pharma industry insiders.
Does Medicare Properly Cover End-of-Life Care for All Beneficiaries?
Investigators evaluate differences in end-of-life care between Medicare beneficiaries in Medicare Advantage vs. traditional Medicare.
Bridging the Divide: Understanding Contrasting Approaches in Drug Development
Analyzing the divergent paths undertaken by small biotech and large pharma companies in drug development.
Susvimo Demonstrates Sustained Efficacy Over Two Years in Patients with Diabetic Macular Edema and Diabetic Retinopathy
FDA to review one-year results for Susvimo showing non-inferior visual acuity gains in diabetic macular edema and in the Diabetic Retinopathy Severity Scale for Diabetic Retinopathy.
Perks of Routing Tests Directly to Physicians’ Offices
In an interview with Pharma Commerce editor Nicholas Saraceno, Matthew Walsh, ixlayer’s general manager of biopharma, dives into efficiencies presented by at-home diagnostic tests.
Sentiments Surrounding At-Home Diagnostic Testing
In an interview with Pharma Commerce editor Nicholas Saraceno, Matthew Walsh, ixlayer’s general manager of biopharma, discusses findings of a new physician survey that the company conducted.
Systech, Praxis Packaging Strike Track-and-Trace Partnership
The agreement revolves around providing and maintaining supply chain transparency.
Cordenpharma Invests $984 Million into Its Peptide Tech Platform
The financial commitment includes a pair of expansion plans occurring in the United States and Europe.
Improving Cross-Industry Collaboration on Drug Discount Programs
How teamwork among safety-net healthcare providers and pharma can make the difference.
Upperton Pharma Solution Passes MHRA Inspection, Simultaneously Invests in Large-Scale Processing
The 50,000 square-foot facility has the ability to handle various batch sizes and dosage forms.
Catalent Finalizes Schorndorf Plant Development Project
The clinical supply facility undergoes a $25 million expansion, welcoming 32,000 more square feet of temperature-controlled storage.
Treating Rheumatoid Arthritis Patients With Biosimilars Versus Leflunomide: An Economic Evaluation
A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.
INCOG BioPharma Invests in Second Manufacturing Building on Indiana Campus
The construction of 100,000 square-foot facility will boost the site's filling capacity to 140 million units per year.
How State Privacy Laws Are Shaping DTC and HCP Marketing Strategies
Why they are a game changer, and ways to a adapt to a new era of state privacy regulations.
Merck Finalizes EyeBio Purchase
The acquisition in the ophthalmology space features a $1.3 billon cash payment, with the potential for an additional $1.7 billion if various milestones are met.
The Relationship Between Patients and Drug Shortages
In an interview with Pharma Commerce editor Nicholas Saraceno, Peter Ax, UpScriptHealth’s founder and CEO, discusses how patients are affected by these supply chain bottlenecks, along with ways to mitigate these complications.
Rentschler Biopharma SE’s New Advanced Production Line Now Fully Operational
New production line represents Rentschler Biopharma SE’s biggest investment in its 150-year history.
The Current Landscape of Drug Shortages
In an interview with Pharma Commerce editor Nicholas Saraceno, Peter Ax, UpScriptHealth's founder and CEO, offers his thoughts surrounding the lack of supply.
The State of Patient Support Services in Today’s Landscape
Why these programs require a hybrid approach that combines technology and human connection.
MedPharm, Tergus Pharma Join Forces
The merger combines the companies under the MedPharma name, creating a topical and transepithelial CDMO in the process.
Determining Drug Development Costs in the United States
An economic evaluation study assesses these costs by therapeutic class, while identifying trends in pharma R&D intensity over time.
SGS North America Strengthens Its Biologics Testing Services
Expansion of these offerings will occur at the company’s 60,000 square-foot Lincolnshire Center of Excellence
Air Freight Demand Continues for May
Double-digit, year-on-year growth is now on a six-month streak.
Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Patients with Obesity and Diabetes
An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.
UPS Healthcare Financially Commits Over $21.6 Million Toward Cold Chain Fleet
The investment is expected to help enhance the company temperature-controlled services in the Netherlands, France, Italy, and Hungary.
FDA Approves Pyzchiva for Use in the United States
The Stelara biosimilar will be commercialized by Sandoz, and is expected to launch by February 2025 for multiple indications, including for the treatment of adult patients with active psoriatic arthritis.
